IBDEI0S6 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13911,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,13911,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,13911,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,13912,0)
 ;;=332.0^^90^853^61
 ;;^UTILITY(U,$J,358.3,13912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13912,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,13912,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,13912,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,13913,0)
 ;;=250.60^^90^853^62
 ;;^UTILITY(U,$J,358.3,13913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13913,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,13913,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,13913,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,13914,0)
 ;;=356.9^^90^853^64
 ;;^UTILITY(U,$J,358.3,13914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13914,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,13914,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,13914,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,13915,0)
 ;;=780.2^^90^853^73
 ;;^UTILITY(U,$J,358.3,13915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13915,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,13915,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,13915,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,13916,0)
 ;;=724.3^^90^853^70
 ;;^UTILITY(U,$J,358.3,13916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13916,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,13916,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,13916,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,13917,0)
 ;;=780.39^^90^853^72
 ;;^UTILITY(U,$J,358.3,13917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13917,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,13917,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,13917,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,13918,0)
 ;;=782.0^^90^853^60
 ;;^UTILITY(U,$J,358.3,13918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13918,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,13918,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,13918,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,13919,0)
 ;;=435.9^^90^853^74
 ;;^UTILITY(U,$J,358.3,13919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13919,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,13919,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,13919,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,13920,0)
 ;;=354.2^^90^853^76
 ;;^UTILITY(U,$J,358.3,13920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13920,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,13920,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,13920,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,13921,0)
 ;;=729.1^^90^853^17
 ;;^UTILITY(U,$J,358.3,13921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13921,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,13921,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,13921,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,13922,0)
 ;;=438.20^^90^853^6
 ;;^UTILITY(U,$J,358.3,13922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13922,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,13922,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,13922,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,13923,0)
 ;;=438.12^^90^853^5
 ;;^UTILITY(U,$J,358.3,13923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13923,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,13923,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,13923,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,13924,0)
 ;;=356.8^^90^853^63
 ;;^UTILITY(U,$J,358.3,13924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13924,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,13924,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
